96561-34-1

Basic information

• Product Name: (2R,3S)-3-(1,3-Benzodioxol-5-yl)-3-hydroxy-2-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl]propionic acid
• Synonyms: (2R,3S)-3-(1,3-Benzodioxol-5-yl)-3-hydroxy-2-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl]propionic acid
• CAS NO: 96561-34-1
• Molecular Formula: C18H13NO7
• Molecular Weight: 355.3
• Mol File: 96561-34-1.mol

Chemical Properties

• Boiling Point: 605.3±55.0 °C(Predicted)
• Appearance: /
• Density: 1.619±0.06 g/cm3(Predicted)
• PKA: 3.04±0.10(Predicted)
• CAS DataBase Reference: (2R,3S)-3-(1,3-Benzodioxol-5-yl)-3-hydroxy-2-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl]propionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-3-(1,3-Benzodioxol-5-yl)-3-hydroxy-2-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl]propionic acid(96561-34-1)
• EPA Substance Registry System: (2R,3S)-3-(1,3-Benzodioxol-5-yl)-3-hydroxy-2-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl]propionic acid(96561-34-1)

Safety Data

• Hazardous Substances Data: 96561-34-1(Hazardous Substances Data)

Upstream product

• 120-57-0 piperonal 
• 22509-74-6 N-ethoxycarbonylphthalimide 
• 96561-36-3 L-threo-(N-phthaloyl-3-(3,4-methylenedioxyphenyl)serine) norephedrine salt 
• 1458647-14-7 2-phthalimido-3-hydroxy-3-(3,4-methylenedioxyphenyl)propionic acid 
• 25543-10-6 N-methoxycarbonylphthalimide 
• 136918-14-4 phthalimide 

Downstream Products

• 96561-53-4 L-threo-(N-phthaloyl-3-(3,4-dihydroxyphenyl)serine) 

Relevant articles and documents

Resolution method of droxidopa key intermediates

The invention relates to a resolution method of droxidopa threo type key intermediates (key intermediate I, key intermediate II and key intermediate III in synthetic routes 1, 2 and 3), which is characterized in that a non-alkaloid, commercially available

A PROCESS FOR THE PREPARATION OF DROXIDOPA

The present invention provides a novel process for the preparation of droxidopa, a synthetic amino acid precursor of norepinephrine. The process is a stereoselective process for the preparation of droxidopa using asymmetric induction and thus avoids synthetic process involving chiral resolution. The present invention also provides novel intermediates of formula V and formula VI.

METHOD OF DROXIDOPA SYNTHESIS

The present application relates to a novel method of preparing L-threo-dihydroxyphenylserine (droxidopa). Specifically, the application is directed to a method of preparing droxidopa via a deprotection step that is an alternative to deprotection steps tha